Hypertension Drug Shown to be Neuroprotective in Parkinson’s

Hypertension Drug Shown to be Neuroprotective in Parkinson’s
Systemic treatment of animal models with Israpidine, a calcium channel inhibitor, reduced mitochondrial stress that might cause Parkinson's, according to a Northwestern Medicine study published in the Journal of Clinical Investigation. Work previously funded by The Cure Parkinson's Trust (CPT) examining calcium channel expression in post-mortem human brain tissue supported the idea that Cav1 calcium channels could increase the metabolic ... read more
Source: Published on 2018-07-13